3 Results for "

JNJ-7706621

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "JNJ-7706621" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-10329
CAS No.: 443797-96-4
Purity:  99.91%
Research Areas:  

Cancer

JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2, with IC50s of 9 nM, 3 nM, 11 nM, and 15 nM for CDK1, CDK2, aurora-A and aurora-B, respectively .
loading...
    loading...
Cat. No.: HY-10329R
CAS No.: 443797-96-4
Research Areas:  

Cancer

JNJ-7706621 (Standard) is the analytical standard of JNJ-7706621 (HY-10329). This product is intended for research and analytical applications. JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2, with IC50s of 9 nM, 3 nM, 11 nM, and 15 nM for CDK1, CDK2, aurora-A and aurora-B, respectively .
loading...
    loading...
Cat. No.: HY-141685
CAS No.: 443798-09-2
Target:  

CDK GSK-3 VEGFR FGFR

Research Areas:  

Cancer

3-Methylthienyl-carbonyl-JNJ-7706621 is a potent and selective inhibitor of cyclin-dependent kinase (CDK), with IC50s of 6.4 nM and 2 nM for CDK1/cyclin B and CDK2/cyclin A, respectively. 3-Methylthienyl-carbonyl-JNJ-7706621 also shows potent inhibition of GSK-3 (IC50=0.041 μM) and modest potency against CDK4, VEGF-R2, and FGF-R2 (IC50=0.11, 0.13, 0.22 μM, respectively). 3-Methylthienyl-carbonyl-JNJ-7706621 can be used for the research of cancer .
loading...
    loading...